These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2211960)

  • 41. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of anti-phosphatidylethanolamine antibodies using flow cytometry.
    Drouvalakis KA; Neeson PJ; Buchanan RR
    Cytometry; 1999 May; 36(1):46-51. PubMed ID: 10331626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE).
    Bertolaccini ML; Murru V; Sciascia S; Sanna G; Khamashta MA
    Thromb Res; 2012 Dec; 130(6):914-8. PubMed ID: 23079292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
    Zhou DC; Dong Y; Pan JQ
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of anti-DNA and anticardiolipin antibodies in systemic lupus erythematosus.
    de Oliveira RM; Bueno C; Viana VS; Yoshinari NH; Cossermelli W; Santiago MB
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):73-5. PubMed ID: 2616989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].
    Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.
    Ichikawa K; Shimada K; Nawata Y; Ishii T; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1988 Oct; 74(1):110-4. PubMed ID: 3146452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases.
    Meyer O; Abuaf N; Cyna L; Homberg JC; Kahn MF; Ryckewaert A
    Clin Exp Immunol; 1987 Sep; 69(3):485-92. PubMed ID: 3311494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoantibodies.
    Akimoto T; Akama T; Kono I; Yamane K; Sumida T
    J Rheumatol; 1999 Mar; 26(3):580-7. PubMed ID: 10090166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.
    Loizou S; Cazabon JK; Walport MJ; Tait D; So AK
    Arthritis Rheum; 1997 Jan; 40(1):103-8. PubMed ID: 9008606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus.
    Takaya M; Ichikawa Y; Kobayashi N; Kawada T; Shimizu H; Uchiyama M; Moriuchi J; Watanabe K; Arimori S
    Clin Exp Rheumatol; 1991; 9(5):495-9. PubMed ID: 1659508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
    Abe H; Tsuboi N; Suzuki S; Sakuraba H; Takanashi H; Tahara K; Tonozuka N; Hayashi T; Umeda M
    J Rheumatol; 2001 May; 28(5):990-5. PubMed ID: 11361227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders.
    Asherson RA; Khamashta MA; Baguley E; Oakley CM; Rowell NR; Hughes GR
    Q J Med; 1989 Dec; 73(272):1103-15. PubMed ID: 2515555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-Ro and Concomitant Anti-La Autoantibodies Strongly Associated With Anti-oxLDL or Anti-Phospholipid Antibody in Systemic Lupus Erythematosus.
    Kurien BT; Fesmire J; Anderson CJ; Scofield RH
    J Clin Rheumatol; 2016 Dec; 22(8):418-425. PubMed ID: 27870764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies.
    Bozic B; Kveder T; Stegnar M; Morosini-Berus E; Kos-Golja M; Peternel P; Rozman B
    Int Arch Allergy Immunol; 1997 Jan; 112(1):19-26. PubMed ID: 8980460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.
    Smirnov MD; Triplett DT; Comp PC; Esmon NL; Esmon CT
    J Clin Invest; 1995 Jan; 95(1):309-16. PubMed ID: 7814631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.